Investment Objective and Approach

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. Fund Manager will follow the AMFI sector classification for deciding the investment universe for the scheme.

The fund's investment philosophy is centered around identifying growth opportunities within India's pharma and healthcare ecosystem. The fund manager builds the portfolio around the following parameters: Endeavors to invest according to Growth at Reasonable Price. Prefers companies that have a long term potential for growth. The fund is generally dominated by large caps, with significant allocation to mid and small caps.

The scheme also maintains flexibility by investing a portion of its assets in other equity instruments outside the pharma sector and debt instruments to optimize returns while managing risk. This diversified approach helps the fund capitalize on the growing healthcare demand in India while maintaining portfolio balance.

Fund Managers

Rupesh Patel, Sonam Udasi is the Current Fund Manager of Tata India Pharma & Healthcare Fund Direct Growth fund.

Rupesh Patel brings extensive expertise to the fund management. Mr. Rupesh Patel holds a Civil Engineering degree and an MBA degree from the Sardar Patel University. Mr. Patel began his career as a Project Manager at Gujarat State Road Development Corporation Ltd. in 1999. He joined CARE Ratings in 2001 as a Deputy General Manager of Corporate Sector Ratings. In 2007, he became the Assistant Vice President of Investments at IndiaReit Fund Advisors Ltd. Mr. Patel joined Tata Mutual Fund as a Deputy General Manager of Investments in 2008. He became the Head of PMS in 2012. A year later, he became a Fund Manager. Mr. Patel manages an AuM of Rs. 4,506 Crore invested in 14 schemes like Tata Large Cap, Tata Midcap, Tata Infrastructure, Tata Ethical, Tata India Tax Savings Fund, etc.

Sonam Udasi is an experienced financial professional with strong research background. Mr.Sonam Udasi holds a Post Graduate Diploma in Business Administration with specialisation in Finance. He joined Prime Securities back in 2007 as the Director of Research. A year later, he became the VP Research and Group Head of Consumers at Brics Securities. In 2010, he was appointed as the Senior Vice President and Head of Research at IDBI Capital. Mr. Udasi joined Tata Asset Management Ltd. in 2014. He manages an AuM of Rs. 12,863 Crore invested in 19 schemes like Tata Banking and Financial Services Fund, Tata India Consumer Fund, Tata Retirement Savings Fund, Tata Equity PE Fund, etc.

About the Fund House (AMC)

Tata Mutual Fund was established in 1994 and is part of the Tata group, one of India's largest and most respected industrial groups. Established in 1994, Tata Asset Management Private Limited has a track record of more than 25 years in investment management. Tata Asset Management Private Limited manages investments of Tata Mutual Fund.

As of 31 March 2024, Tata Asset Management Ltd has an asset under management (AuM) of Rs. 147169.65 Crores. The fund house operates with three core principles: performance, service, and trust. It has over 35 schemes across equity, debt and hybrid fund categories, offering investors a comprehensive range of investment options.

Tata Asset Management is registered with SEBI and maintains high corporate governance standards, being part of the renowned Tata Group known for its ethical business practices and long-term value creation approach.

Should I Invest in Tata India Pharma & Healthcare Fund?

This fund is suitable for investors seeking long-term capital appreciation through exposure to India's growing pharma and healthcare sector. The TATA India Pharma and Healthcare Fund Direct Plan Growth is a good option for investors who are looking for a long-term investment in the Indian pharmaceutical and healthcare sector. The fund is suitable for investors who have a medium to high risk tolerance and who are looking for a relatively stable investment.

Key considerations for investment:

- Risk Profile: The Tata India Pharma & Healthcare Fund Direct Growth is rated Very High risk.

- Minimum Investment: Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹5,000.

- Exit Load: Exit load of 0.25% if redeemed within 30 days.

The fund has shown strong performance with annualized returns for the past 3 years & 5 years has been around 25.97% & 20.53%. However, it is important to note that the fund is not a risk-free investment. The fund's returns can go down as well as up. Investors should only invest in the fund if they are comfortable with the risk of losing money.

FAQs

What is today's NAV of Tata India Pharma & Healthcare Fund?

The Latest NAV as of 23 Jul 2025 is ₹35.74. NAV changes daily based on market conditions and underlying asset performance.

What is the AUM of Tata India Pharma & Healthcare Fund?

The AUM (i.e. assets under management) of Tata India Pharma & Healthcare Fund is ₹1281.99 Cr as of 21st July 2025.

What is the expense ratio of Tata India Pharma & Healthcare Fund?

The expense ratio of Tata India Pharma & Healthcare Fund Plan is 0.62 as of 21st July 2025.

What are the returns of Tata India Pharma & Healthcare Fund since inception?

Tata India Pharma & HealthCare Fund Direct-Growth scheme return performance in last 1 year is 12.91%, in last 3 years is 98.42% and 256.16% since scheme launch.

What is the minimum SIP amount to invest in Tata India Pharma & Healthcare Fund?

Minimum SIP Investment is set to ₹100. This makes it accessible for small investors to start their investment journey.

How do I invest in Tata India Pharma & Healthcare Fund?

You can invest through Allvest platform, directly from Tata Mutual Fund website, or through registered mutual fund distributors. Complete your KYC process and choose between lump sum or SIP investment options.

How to start a SIP in Tata India Pharma & Healthcare Fund?

Register with Allvest, complete KYC verification, select the fund, choose SIP option, set investment amount (minimum ₹100), select frequency, and provide bank details for auto-debit.

How do I automate an SIP in Tata India Pharma & Healthcare Fund?

Set up auto-debit mandate through Allvest platform by providing bank account details and authorizing automatic monthly deductions. This ensures regular investments without manual intervention.

How can I withdraw/redeem my investment in Tata India Pharma & Healthcare Fund?

Submit redemption request through Allvest platform or fund house website. Funds are typically credited within 3-4 working days. Note the exit load of 0.25% if redeemed within 30 days.